Present case showed that administration of anti-RANKL antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a women patient with aGHD concomitant with NASH. The gene discussed is TNFSF11; the disease is metabolic dysfunction-associated steatohepatitis.